Thursday, March 26, 2009

Watson Recalls Propafenone HCL Tablets Due to Oversized Tablets

Recent increases in recalls due to quality issues have highlighted a need for Quality Assurance (QA) and Quality Control (QC) post packaging within the supply chain especially given the high concentration of contract production/packaging done overseas. One such recall is listed below:

This week Watson Pharmaceuticals, a leading specialty pharmaceutical recalled one lot of Propafenone HCL 225 mg tables in 100 count bottles. This lot number 1112680A with an expiration date of July 31, 2010 is being recalled due to slightly higher levels of the active ingredient.

Propafenone is a medication used to treat cardiac arrhythmias (irregular heartbeats). Some patients who are sensitive may experience potentially serious side effects, including irregular heartbeats or low blood sugar.

More information on this recall is available at:

No comments: